Apparent treatment-resistant hypertension among ambulatory hypertensive patients: a cross-sectional study from 13 general hospitals
1
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Background/Aims: To examine the prevalence and clinical characteristics of apparent treatment-resistant hypertension among ambulatory hypertensive patients. Methods: We enrolled adult ambulatory hypertensive patients at 13 well-qualified general hospitals in Korea from January to June 2012. Apparent resistant hypertension was defined as an elevated blood pressure > 140/90 mmHg with the use of three antihypertensive agents, including diuretics, or ≥ 4 antihypertensives, regardless of the blood pressure. Controlled hypertension was defined as a blood pressure within the target using three antihypertensives, including diuretics. Results: Among 16,915 hypertensive patients, 1,172 (6.9%) had controlled hypertension, and 1,514 (8.9%) had apparent treatment-resistant hypertension. Patients with apparent treatment-resistant hypertension had an earlier onset of hypertension (56.8 years vs. 58.8 years, p = 0.007) and higher body mass index (26.3 kg/m2 vs. 24.9 kg/m2, p < 0.001) than those with controlled hypertension. Drug compliance did not differ between groups. In the multivariable analysis, earlier onset of hypertension (odds ratio [OR], 0.98; 95% confidence interval [CI], 0.97 to 0.99; p < 0.001) and the presence of comorbidities (OR, 2.06; 95% CI, 1.27 to 3.35; p < 0.001), such as diabetes mellitus, ischemic heart disease, heart failure, and chronic kidney disease, were independent predictors. Among the patients with apparent treatment-resistant hypertension, only 5.2% were receiving ≥ 2 antihypertensives at maximally tolerated doses. Conclusions: Apparent treatment-resistant hypertension prevalence is 8.9% among ambulatory hypertensive patients in Korea. An earlier onset of hypertension and the presence of comorbidities are independent predictors. Optimization of medical treatment may reduce the rate of apparent treatment-resistant hypertension.
Abstract
Background/Aims: To examine the prevalence and clinical characteristics of apparent treatment-resistant hypertension among ambulatory hypertensive patients. Methods: We enrolled adult ambulatory hypertensive patients at 13 well-qualified general hospitals in Korea from January to June 2012. Apparent resistant hypertension was defined as an elevated blood pressure > 140/90 mmHg with the use of three antihypertensive agents, including diuretics, or ≥ 4 antihypertensives, regardless of the blood pressure. Controlled hypertension was defined as a blood pressure within the target using three antihypertensives, including diuretics. Results: Among 16,915 hypertensive patients, 1,172 (6.9%) had controlled hypertension, and 1,514 (8.9%) had apparent treatment-resistant hypertension. Patients with apparent treatment-resistant hypertension had an earlier onset of hypertension (56.8 years vs. 58.8 years, p = 0.007) and higher body mass index (26.3 kg/m2 vs. 24.9 kg/m2, p < 0.001) than those with controlled hypertension. Drug compliance did not differ between groups. In the multivariable analysis, earlier onset of hypertension (odds ratio [OR], 0.98; 95% confidence interval [CI], 0.97 to 0.99; p < 0.001) and the presence of comorbidities (OR, 2.06; 95% CI, 1.27 to 3.35; p < 0.001), such as diabetes mellitus, ischemic heart disease, heart failure, and chronic kidney disease, were independent predictors. Among the patients with apparent treatment-resistant hypertension, only 5.2% were receiving ≥ 2 antihypertensives at maximally tolerated doses. Conclusions: Apparent treatment-resistant hypertension prevalence is 8.9% among ambulatory hypertensive patients in Korea. An earlier onset of hypertension and the presence of comorbidities are independent predictors. Optimization of medical treatment may reduce the rate of apparent treatment-resistant hypertension.
참고문헌 (31)
- Lewington S, "Age-specific relevance of usual blood pressure to vascular mortality : a meta-analysis of individual data for one million adults in 61prospective studies", Lancet, 360, pp.1903~1913 (2002)
- Adler AI, "Association of systolic blood pressure with macrovascular and microvascular complications of type 2 diabetes(UKPDS 36) : prospective observational study", BMJ, 321, pp.412~419 (2000)
- SPRINT Research Group, "A randomized trial of intensive versus standard blood-pressure control", N Engl J Med, 373, pp.2103~2116 (2015)
- Hajjar I, "Trends in prevalence, awareness, treatment, and control of hypertension in the United States, 1988-2000", JAMA, 290, pp.199~206 (2003)
- Epstein M, "Resistant hypertension: prevalence and evolving concepts", J Clin Hypertens (Greenwich), 9(1 Suppl 1), pp.2~6 (2007)
- Egan BM, "Uncontrolled and apparent treatment resistant hypertension in the United States, 1988 to 2008", Circulation, 124, pp.1046~1058 (2011)
- Judd E, "Apparent and true resistant hypertension : definition, prevalence and outcomes", J Hum Hypertens, 28, pp.463~468 (2014)
- Bangalore S, "Prevalence, predictors, and outcomes in treatment-resistant hypertension in patients with coronary disease", Am J Med, 127, pp.71~81 (2014)
- Chobanian AV, "Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure", Hypertension, 42, pp.1206~1252 (2003)
- McAdam-Marx C, "Results of a retrospective, observational pilot study using electronic medical records to assess the prevalence and characteristics of patients with resistant hypertension in an ambulatory care setting", Clin Ther, 31, pp.1116~1123 (2009)
- Falaschetti E, "Continued improvement in hypertension management in England : results from the health survey for England 2006", Hypertension, 53, pp.480~486 (2009)
- Persell SD, "Prevalence of resistant hypertension in the United States, 2003-2008", Hypertension, 57, pp.1076~1080 (2011)
- Sim JJ, "Characteristics of resistant hypertension in a large, ethnically diverse hypertension population of an integrated health system", Mayo Clin Proc, 88, pp.1099~1107 (2013)
- Lee KN, "Prevalence and characteristics of resistant hypertension at primary clinics in Korea : a nationwide cross-sectional study", Clin Hypertens, 22, pp.4~ (2016)
- Choi SW, "Apparent treatment-resistant hypertension among elderly Korean hypertensives : an insight from the HIT registry", J Hum Hypertens, 28, pp.201~205 (2014)
- Choi SI, "Prevalence of resistant hypertension and associated factors for blood pressure control status with optimal medical therapy using Korean ambulatory blood pressure monitoring registry data", Clin Hypertens, 22, pp.8~ (2016)
- Black HR, "Baseline characteristics and early blood pressure control in the CONVINCE trial", Hypertension, 37, pp.12~18 (2001)
- Dahlof B, "Cardiovascular morbidity and mortality in the Losartan Intervention for Endpoint reduction in hypertension study(LIFE) : a randomised trial against atenolol", Lancet, 359, pp.995~1003 (2002)
- Lloyd-Jones DM, "Differential control of systolic and diastolic blood pressure : factors associated with lack of blood pressure control in the community", Hypertension, 36, pp.594~599 (2000)
- Cushman WC, "Success and predictors of blood pressure control in diverse North American settings : the antihypertensive and lipid-lowering treatment to prevent heart attack trial(ALLHAT)", J Clin Hypertens (Greenwich), 4, pp.393~404 (2002)
- Calhoun DA, "Resistant hypertension : diagnosis, evaluation, and treatment : a scientific statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research", Hypertension, 51, pp.1403~1419 (2008)
- Williams B, "Spironolactone versus placebo, bisoprolol, and doxazosin to determine the optimal treatment for drug-resistant hypertension(PATHWAY-2) : a randomised, double-blind, crossover trial", Lancet, 386, pp.2059~2068 (2015)
- Bramlage P, "Hypertension in overweight and obese primary care patients is highly prevalent and poorly controlled", Am J Hypertens, 17, pp.904~910 (2004)
- Caro JJ, "Effect of initial drug choice on persistence with antihypertensive therapy : the importance of actual practice data", CMAJ, 160, pp.41~46 (1999)
- Mazzaglia G, "Patterns of persistence with antihypertensive medications in newly diagnosed hypertensive patients in Italy : a retrospective cohort study in primary care", J Hypertens, 23, pp.2093~2100 (2005)
- Ho PM, "Importance of therapy intensification and medication nonadherence for blood pressure control in patients with coronary disease", Arch Intern Med, 168, pp.271~276 (2008)
- Brown MA, "Is resistant hypertension really resistant?", Am J Hypertens, 14, pp.1263~1269 (2001)
- Santos LP, "Effects of aerobic exercise intensity on ambulatory blood pressure and vascular responses in resistant hypertension : a crossover trial", J Hypertens, 34, pp.1317~1324 (2016)
- Whelton SP, "Effect of aerobic exercise on blood pressure : a meta-analysis of randomized, controlled trials", Ann Intern Med, 136, pp.493~503 (2002)
- Whelton PK, "2017 ACC", AHA, ABC, pp.ACPM, AGS[DOI]
- Carey RM, "Resistant hypertension : detection, evaluation, and management : a scientific statement from the American Heart Association", Hypertension, 72, pp.e53~e90 (2018)